Adverse reactions of high-osmolar and low-osmolar radiographic contrast media in clinical practice

Introduction. Adverse drug reactions (ADR) to administration of radiographic contrast media (RCM) are observed in 10–20 % of patients. Individual tolerability of drugs is affected by RCM properties (ionicity, osmolarity). Aim. Evaluation of ADR in patients during diagnostic studies using high- and low-osmolar RCM. Methods. Analysis of 52 reports of adverse reactions to RCM registered in medical organizations of Voronezh region in 2014–2021 was performed. Group 1 included 21 patients with ADR to high-osmolar RCM (sodium amidotrizoate, yoxitalamic acid), group 2–31 patients with ADR to low-osmolar drugs (yogexol, yopromide, yopamidol, yoversol). Results. Age of patients is 6–82 years, median 48.5 years, children — 8 persons (15.4 %), women — 31 patients (59.6 %), serious reactions — 28 (53.8 %). Since 2017 there has been an increase in the number of ADRs with constant frequency of serious reactions. In 2020–2021 ADRs to low-osmolar drugs were mainly registered. Life-threatening conditions (anaphylactic shock, arterial hypotension, arrhythmia) were observed in 70.2 % of group 2, in 28.6 % of group 1 (p=0.007). One patient with initial renal dysfunction and comorbid pathology was reported to develop nephrotoxicity to yogexol. Pharmacological correction was performed in 92.3 % of cases. In 57.7 % of the patients ADR ended in recovery, in the  other cases — state improvement. Conclusion. Side effects of high-osmolar and low-osmolar RCM mainly had form of hyperergic reactions of immediate type and were reversible. High frequency of serious reactions to lowosmolar RCM against an increase in their use requires a more careful selection of patients for X-ray contrast studies.

1. Fominyh VP, Fineshin IN, Sharikov PV. Roentgen contrast media. View of resuscitator. Russian electronic journal of radiology. 2012;2(1):35–43. (In Russ).

2. Akhmedzyanova DG, Rakhmatullina NM, Sibgatullina NA, et al. Acute adverse reactions for contrast medium infiltration in medical practice. The Bulletin of Contemporary Clinical Medicine. 2018;11(5):100–4. (In Russ). doi:10.20969/vskm.2018.11(5).100–104

3. Krylova AI, Sotnikova EA, Golbits AB. The use of contrast media in radiology in children. Pediatrician. 2016;7(1):111–9. (In Russ). doi:10.17816/ped71111-119

4. Raptanova VA, Speranskaya AA, Proshin SN. Proshin contrast-induced nephropathy (pharmacology of x-ray contrast agents). Pediatrician. 2016;7(1):97–105. (In Russ). doi:10.17816/ped7197-105

5. Van der Molen AJ, Thomsen HS, Morcos SK et al. Effect of iodinated contrast media on thyroid function in adults. European Radiology. 2004;14(5):902–7. doi:10.1007/s00330-004-2238-z

6. Katzberg RW, Haller C. Contrast-induced nephrotoxicity: clinical landscape. Kidney Int Suppl. 2006;(100): S3–7. doi:10.1038/sj.ki.5000366

7. Moisey RS, McPherson S, Wright M, Orme SM. Thyroiditis and iodide mumps following an angioplasty. Nephrol Dial Transplant. 2007;22(4):1250–2. doi:10.1093/ndt/gfl777

8. Trumbo P, Yates AA, Schlicker S, Poos M. Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. J Am Diet Assoc. 2001;101(3):294–301. doi:10.1016/S0002–8223(01)00078-5

9. Sendeski MM. Pathophysiology of renal tissue damage by iodinated contrast media. Clin Exp Pharmacol Physiol. 2011;38(5):292–9. doi:10.1111/j.1440-1681.2011.05503.x

10. Leung AM, Braverman LE. Iodine-induced thyroid dysfunction. Curr Opin Endocrinol Diabetes Obes. 2012;19(5):414–9. doi:10.1097/MED.0b013e3283565bb2

11. Eng PHK, Cardona GR, Fang S et al. Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein. Endocrinology. 1999;140(8):3404–10. doi:10.1210/endo.140.8.6893

12. Martins MC, Lima N, Knobel M, Medeiros-Neto G. Natural course of iodine-induced thyrotoxicosis (Jodbasedow) in endemic goiter area: a 5 year follow-up. J Endocrinol Invest. 1989;12(4):239–44. doi:10.1007/BF03349973

13. Bürgi H. Iodine excess. Best Pract Res Clin Endocrinol Metab. 2010;24(1):107–15. doi:10.1016/j.beem.2009.08.010

14. Rhee CM, Bhan I, Alexander EK, Brunelli SM. Association between iodinated contrast media exposure and incident hyperthyroidism and hypothyroidism. Arch Intern Med. 2012;172(2):153–9. doi:10.1001/archinternmed.2011.677

15. Thomson KR, Varma DK. Safe use of radiographic contrast media. Aust Prescr. 2010;33:35–7. doi.org/10.18773/austprescr.2010.006

16. Gartner W, Weissel M. Do iodine-containing contrast media induce clinically relevant changes in thyroid function parameters of euthyroid patients within the first week? Thyroid. 2004;14(7):521–4. doi:10.1089/1050725041517075

17. Petrov VI, Kudasheva AA, Frolov DV. Contrast-induced nephropathy: prevalence, diagnosis, prevention and treatment. Journal of Volgograd State Medical University. 2022;19(2):7–18. (In Russ). doi:10.19163/1994-9480-2022-19-2-7-18

18. Mitchеll AM, Jonеs AЕ, Tumlin JA, Klinе JA. Incidеncе of contrastinducеd nеphropathy aftеr contrastеnhancеd computеd tomography in thе outpatiеnt sеtting. Clin J Am Soc Nephrol. 2010;5(1):4–9. doi:10.2215/CJN.05200709

19. Katzberg RW, Newhouse JH. Intravenous contrast medium-induced nephrotoxicity: is the medical risk really as great as we have come to believe? Radiology. 2010;256(1):21–8. doi:10.1148/radiol.10092000

20. Solomon R. Contrast-induced acute kidney injury: is there a risk after intravenous contrast? Clin J Am Soc Nephrol. 2008;3(5):1242–3. doi:10.2215/CJN.03470708

21. Tsygina EN, Smirnov IE, Kucherenko AG et al. Studies of safety and functional and metabolic effects of non-ionic contrast media in children with nephropathies. Pediatric pharmacology. 2010;7(2):78–82. (In Russ).

22. Lightfoot CB, Abraham RJ, Mammen T et al. Survey of radiologists’ knowledge regarding the management of severe contrast materialinduced allergic reactions. Radiology. 2009;251(3):691–6. doi:10.1148/radiol.2513081651

23. Loh S, Bagheri S, Katzberg RW et al. Delayed adverse reaction to contrast-enhanced CT: a prospective single-center study comparison to control group without enhancement. Radiology. 2010;255(3):764–71. doi:10.1148/radiol.10091848

24. Keller M, Lerch M, Britschgi M et al. Processing-dependent and -independent pathways for recognition of iodinated contrast media by specific human T cells. Clin Exp Allergy. 2010;40(2):257–68. doi:10.1111/j.1365-2222.2009.03425.x

25. Chiu T-M, Chu S-Y. Hypersensitivity Reactions to Iodinated Contrast Media. Biomedicines. 2022;10(5):1036. doi:10.3390/biomedicines10051036

26. Standartnaya operatsionnaya protsedura monitoringa effektivnosti i bezopasnosti lekarstvennykh preparatov v meditsinskikh organizatsiyakh gosudarstvennoi sistemy zdravookhraneniya goroda Moskvy dlya vrachei obshchei praktiki i srednego meditsinskogo personala: metodicheskie rekomendatsii / ed. by Zhuravleva MV.— Moscow, 2007. (In Russ).

27. WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC classifi cation and DDD assignment 2020. Oslo, Norway, 2019.

28. Petrukhina IK, Kurkin VA, Ezhkov VN. Monitoring of the adverse reactions of the prescribed medicinal drugs in the Volga federal district. Fundamental Research. 2015;2(14):3126–30. (In Russ).

29. Matveev AV, Krasheninnikov AЕ, Egorova EA. Investigation of the safety of radiopaque compounds based on notification cards on adverse reactions registered in the republic of Crimea. Vestnik rentgenologii i radiologii. 2020;101(6):344–53. (In Russ). doi:10.20862/0042-4676-2020-101-6-344-353

30. Aykan AÇ, Aykan DA, Katırcıbaşı MT, Özgül S. Management of radiocontrast allergy in radio-contrast allergic patients undergoing coronary angiography and intervention. Kardiologiia. 2020;60(10):62–5. doi:10.18087/cardio.2020.10.n1117

31. Gombolevskii VA, Laipan ASh, Badyul MI et al. Osobennosti primeneniya kontrastnykh preparatov v luchevoi diagnostike.— Moscow, 2018. — (Luchshie praktiki luchevoi i instrumental’noi diagnostiki; is. 15). (In Russ).